Table 1.
Baseline Characteristics | |
---|---|
Characteristic | All Patients (n = 8) n (%) |
Median age, years (range) | 69 (60–76) |
Sex | |
Male | 6 (75%) |
Female | 2 (25%) |
Race | |
White | 5 (63%) |
Asian | 2 (25%) |
African American | 1 (13%) |
ECOG a | |
0 | 3 (38%) |
1 | 5 (63%) |
BCLC Stage b | |
A | 5 (63%) |
B | 1 (13%) |
C | 2 (25%) |
Child Pugh Score | |
A | 8 (100%) |
B | 0 (0%) |
Hepatitis C Status | |
Positive | 5 (63%) |
Negative | 3 (38%) |
Hepatitis B Status | |
Positive | 1 (13%) |
Negative | 7 (88%) |
Prior systemic treatment | |
Yes | 0 (0%) |
No | 8 (100%) |
Prior local therapy | |
Yes | 4 (50%) |
No | 4 (50%) |
Baseline AFP level | |
≥ 400 µg/L | 2 (25%) |
≤ 400 µg/L | 6 (75%) |
aECOG: Eastern Cooperative Oncology Group; bBCLC: Barcelona clinic liver cancer